But for India, this story needs a bit of alteration, as technology alone cannot bridge the gaps that exist in cancer care here. For our country, a bigger challenge would be to ensure adequate accessibility to these advanced diagnostics and therapies. And that’s not all. India will also need to develop a strong indigenous pipeline of targeted drugs, antibodies and cell therapies, said Dr. Maitra. In addition to this, locally generated data will also be crucial for AI systems to work accurately for Indian patients.

Posted inBlog
